GNS.L
GNS.L
GB0002074580
GENUS PLC ORD 10P
Loading chart...

Company Profile

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

Related stocks

ONT.L
ONT.L • United Kingdom
OXFORD NANOPORE TECHNOLOGIES PL
213.4 GBp
2.76B USD 1Y +34.5%
IMCR
IMCR • United Kingdom
Immunocore Holdings plc
29.39 USD
1.51B USD 1Y -14.4%
OXB.L
OXB.L • United Kingdom
OXFORD BIOMEDICA PLC ORD 50P
521 GBp
834.6M USD 1Y -20.8%
BAVA.CO
BAVA.CO • Denmark
Bavarian Nordic A/S
236.8 DKK
2.67B USD 1Y -0.7%
QURE
QURE • Netherlands
uniQure N.V.
22.59 USD
1.57B USD 1Y -62.4%
MEDCL.PA
MEDCL.PA • France
MEDINCELL S.A.
29.06 EUR
1.17B USD 1Y -11.3%
ZEAL.CO
ZEAL.CO • Denmark
Zealand Pharma A/S
238 DKK
2.37B USD 1Y -53.5%
SLNCF
SLNCF • United Kingdom
Silence Therapeutics, Plc.
4 USD
745.85M USD 1Y +150%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
39.3% p.a.
Max Drawdown (5Y)
-74.7%
Sharpe Ratio (5Y)
-0.47
Beta Factor
0.91
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (39.3% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -76.5% in the extended horizon.
ende